Johan K. Wallman
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.
Journal: EULAR rheumatology open
Published: June 29, 2026
Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.
Journal: The Journal of rheumatology
Published: June 15, 2026
Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.
Journal: The Journal of rheumatology
Published: June 15, 2026
Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries.
Journal: Annals of the rheumatic diseases
Published: February 20, 2026
Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.
Journal: Annals of the rheumatic diseases
Published: February 11, 2026
Axial spondyloarthritis patients with comorbid fibromyalgia feel worse, work less and more often try multiple biological therapies: results from a population-based, cross-sectional study investigating the discriminative capacity of pressure algometry.
Journal: Rheumatology international
Published: December 17, 2025
Known and less well-known comorbidities in axial spondyloarthritis: what are we overlooking? Results from the SPARTAKUS cohort.
Journal: Scandinavian journal of rheumatology
Published: September 01, 2025
Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis: A Swedish Nationwide Registry Study.
Journal: The Journal of rheumatology
Published: April 22, 2025
Gut inflammation is associated with structural spinal damage in axial spondyloarthritis - results from the observational SPARTAKUS cohort.
Journal: Arthritis research & therapy
Published: January 13, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network.
Journal: The Journal of rheumatology
Published: January 02, 2025
Last Updated: 09/26/2026